Haematologica (Oct 2024)
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
- Malin Hultcrantz,
- David Kleinman,
- Ravi Vij,
- Fernando Escalante,
- Michel Delforge,
- Nirali Kotowsky,
- Jacopo Bitetti,
- Natalie Boytsov,
- Leena Camadoo-O'Byrne,
- Lindsey Powers Happ,
- Guillaume Germain,
- Ana Urosevic,
- Malena Mahendran,
- Mei Sheng Duh,
- Francois Laliberte,
- Michele Cavo,
- Hans C. Lee
Affiliations
- Malin Hultcrantz
- Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY
- David Kleinman
- Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY
- Ravi Vij
- Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO
- Fernando Escalante
- Hematology Department, University Hospital of Leon, Leon
- Michel Delforge
- Department of Hematology, Catholic University of Leuven, Leuven
- Nirali Kotowsky
- Value, Evidence and Outcomes, GSK, Upper Providence, PA
- Jacopo Bitetti
- Global Medical Affairs, GSK, Zug
- Natalie Boytsov
- Value, Evidence and Outcomes, GSK, Upper Providence, PA
- Leena Camadoo-O'Byrne
- Real World Study Delivery, GSK, Stevenage
- Lindsey Powers Happ
- Real World Data Strategy and Partnerships, Value, Evidence and Outcomes, GSK, Collegeville, PA
- Guillaume Germain
- Groupe d’Analyse, Ltee., Montreal, Quebec
- Ana Urosevic
- Groupe d’Analyse, Ltee., Montreal, Quebec
- Malena Mahendran
- Groupe d’Analyse, Ltee., Montreal, Quebec
- Mei Sheng Duh
- Analysis Group, Inc., Boston, MA
- Francois Laliberte
- Groupe d’Analyse, Ltee., Montreal, Quebec
- Michele Cavo
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”, Universita degli Studi di Bologna, Bologna
- Hans C. Lee
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
- DOI
- https://doi.org/10.3324/haematol.2024.285893
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
